| INTRODUCTION
Squamous cell carcinoma temporal bone (SCCTB) is a rare malignancy with incidence of around 1 to 1.2 case per million populations per year. Risk factors included chronic otitis media and chronic irritation of the skin and mucosa of the external and middle ear. 1 A rare but important aetiology is radiation to the region for treatment of head and neck malignancies. Radiation treatment for nasopharyngeal carcinoma (NPC) appears an important association of post-irradiated SCC of temporal bone in South-East Asia as demonstrated by previous reported cohorts from Taiwan and Singapore. [2] [3] [4] This study investigates and compares the presentation, treatment and prognosis of de novo SCCTB (dnSCC) and post-irradiated SCCTB (piSCC). We investigate whether prior irradiation to the region would limit on treatment options and leading to difference in survival and local disease control of piSCC compared to dnSCC.
| ME TH ODS
We reviewed our department's database and retrieved all temporal bone squamous cell carcinoma treated from June 1995 to June 2016. Only patients with complete clinical data were included. The study was approved by our hospital's ethics committee.
All patients have histological diagnosis of SCC of the external auditory canal or mastoid. SCC of the auricle and pinna was excluded. 36.7% patients had MRI scan in addition to CT scan performed for tumour staging. In our institute, all the patients with NPC were followed up lifelong by the otorhinolaryngologist.
We analysed the clinical characteristics and treatment outcome and further divided the patients into de novo group (dnSCC) with no prior radiation to the head and neck region and the piSCC, who all had received radiation treatment. Post-irradiation malignancy is defined as development of a new malignancy with different histology within the field of previous radiation treatment diagnosed after a latent period of 5 years, and which is histologically different from the initial malignancy. 5 Modified Pittsburgh Classification 6 was used to stage the SCC temporal bone. 6 Comparisons were made on the stage at presentation, disease-free survival (DFS) and overall survival (OS).
All data were collected retrospectively. SPSS There was no difference in baseline characteristics (Table 1A) .
Mean age of SCC presentation was 64.8 years old. In the piSCC group, the mean age of diagnosis of the NPC was 48.3 years old.
Male pre-dominance was observed in both groups.
10% of the tumour has initial negative biopsy result, including squamous papilloma, inflamed granulation tissue, cholesteatoma and inflammatory polyp. Histological diagnosis of SCC temporal bone was confirmed in later biopsy or operative specimen.
The median latency period of piSCC is 16.8 years, ranges from 5.76 to 29.1 years. It is consistent with previous reports that the median latency period of piSCC is 17-18.8 years and can be as long as three decades. 3, 4 In our current cohort, bilateral sequential piSCC of temporal bone occurred in one male and one female patient with NPC, the latency period is 12.6 year and 10.0 year, respectively. The first incidence of SCC temporal bone of the female patient occurred in 1992; therefore, the episode was excluded from the current cohort. The incidence of sequential contralateral piSCC of temporal bone is 13.3%. (Table 2) .
T A B L E 1 Patients Characteristics
Lymph node metastasis is uncommon at presentation, in which only two patients (7%) had N2 disease at presentation. There was no statistical difference in the initial N Stage (Table 2 ).
| Treatment
Two patients received radiotherapy alone and one patient received chemo-radiation alone. 25 cases were treated with curative intent surgery and two cases in the piSCC group were treated with palliative surgery for pain relief: 11 (40.7%) radical mastoidectomies, 10 Significantly more patients (84.6%) in dnSCC group received postoperative adjuvant treatment comparing to only 14.3% of the piSCC group (Table 2) .
| Outcome
The follow-up period ranged from five to 245 months. Estimated median OS, disease-specific survival (DSS) and DFS of the whole cohort were 45, 48 and 18 months, respectively.
Median OS of dnSCC group and piSCC group is 23 months • Bilateral sequential piSCC in NPC survivors is not uncommon. 13% of patient with piSCC in our series has bilateral disease.
• Long latency period of piSCC indicates lifelong surveillance of patients with NPC might be necessary, in which early detection can be achieved as demonstrated in our series.
• Lower T-stage and overall stage can translate to superior overall and DFS of SCC temporal bone.
• Prognosis of piSCC and dnSCC remains similar despite early detection of piSCC in our series, which may be attributed by the limitation in administration of adjuvant treatment in patients with piSCC, and therefore, achieving a negative surgical margins is seemed to offer best outcome for patients with piSCC temporal bone.
None of the patients with piSCC develop distant or nodal metastasis within the follow-up period, comparing to 35.7% in the dnSCC group.
| DISCUSSION
Nasopharyngeal carcinoma is prevalent in Hong Kong. According to the Hong Kong Cancer Registry, yearly incidence of NPC in our locality ranges from 800-900. Prior radiation therapy for NPC is the most common cause of piSCC temporal bone in Hong Kong, constituting all cases in our series.
Due to rarity of disease, management strategies were guided by limited number of available cohort series and literature reviews. [7] [8] [9] In particular, limited information on piSCC was avail- In the present cohort, piSCC group of patients presents with earlier disease then dnSCC group. This may be due to the regular follow up of the patients with NPC by otolaryngologist and early biopsy of suspicious lesions in the ear. On the contrary, patients with dnSCC usually have chronically discharging ears that they elect to disregard the symptoms and not seek medical care until when symptoms of more advance disease like pain and significant bleeding occur.
It would be expected that with earlier presentation, the piSCC group should enjoy a better survival. However, adjuvant radiation was usually not given to piSCC group of patients after radical surgery to avoid excessive toxicity to the surrounding tissue. The lack of adjuvant radiation in the piSCC group may explain the similar disease control and survival despite earlier presentation of the disease.
As the anatomy of the temporal bone is complex with many vital structures in proximity, a true negative resection margins may not be easily achieve and adjuvant radiation may have a role in controlling the microscopic residual diseases.
Survival of piSCC is generally poor, the 3-year OS ranges from 20%-60%. Literature data on comparison prognosis of piSCC and dnSCC remained inconsistent. Lo et al. 3 in 2000 suggested inferior prognosis in patients with piSCC, whereas latest series in 2014 by Tay et al. 4 suggested similar prognosis between the two groups.
Optimal treatment strategy and surgical approach still remains controversial.
Role of elective neck dissection and parotidectomy is controversial. [7] [8] [9] In our series, all patients with piSCC did not receive elective 
| INTRODUCTION
Hyoid suspension is a part of a multilevel surgery concept aiming at treatment of obstructive sleep apnoea (OSA). Since its early description, hyoid suspension was used by many authors for correction of hypopharyngeal airway obstruction. Initially, hyoid suspension was designed so that the hyoid bone was suspended to the inferior border of the mandible using fascia lata. Later, Riley et al., 1993 modified the technique and secured the hyoid bone to the thyroid cartilage. 1 Since that, many modifications were published in trials to optimise its outcome, and to deal with its complications, for example pharyngeal perforation and thyroid cartilage fracture. [1] [2] [3] In this work, the authors present a modification to hyoid suspension surgery. The described technique uses a single triangular absorbable suture between the hyoid body and the thyroid laminae.
| PATIENTS AND METHODS
This prospective study was carried out at the Otorhinolaryngology Department, Zagazig University; Egypt. 
| Ethical consideration
The institutional review board (IRB) approved the research methodology. The study was conducted according to the declaration of Helsinki on Biomedical Research Involving Human Subjects.
| Settings
This prospective study was conducted at the Otorhinolaryngology Head and Neck Surgery department, Zagazig University Hospitals, from February 2012 to November 2016.
| Inclusion and exclusion criteria
The study included patients with OSA symptoms with apnoea hypopnea index (AHI) >15, who had body mass index (BMI) <30 kg/m 2 and showed predominant lateral wall hypopharyngeal collapse (with or without other levels) during preoperative preparation.
| Preoperative preparation
After their consents and history, patients had subjective analysis beginning at the inferior border and pushed to exit in the midline immediately above the superior border. Then, the needle was directed to the left thyroid lamina piercing it from inner to outer side, about 1/2 cm from the upper border of the cartilage. Then, the needle was directed towards the right lamina (with the thread in front of the cartilage below the thyroid notch) piercing it from outer to inner side (i.e it exited from the medial surface) about 1/
